Biotechnology
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses MORRISVILLE, N.C., Oct. 20, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in met...
2026-10-20 21:00
4354
G-NiiB GenieBiome Named an Inaugural Hong Kong New Industrialisation Elite Enterprise
Recognition highlights Hong Kong's strength in university research translation and life and health technology industrialisation HONG KONG, Oct. 20, 2026 /PRNewswire/ -- G–NiiB GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong, has been named one of Hong Kong's inaugura...
2026-10-20 20:46
1973
Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia
Bellberry Limited Research Ethics Committee approves first-in-human study in Australia of Patronus Biotech's novel multi-stage virus-like-particle (VLP)-based malaria vaccine candidates targeting Plasmodium falciparum and Plasmodium vivax GUANGZHOU, China, Oct. 20, 2026 /PRNewswire/ -- Patronus ...
2026-10-20 20:40
1878
New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD
A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...
2026-10-20 14:10
1176
Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity
- Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combinations. - ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug candidate of Ascletis' once-weekly oral peptide p...
2026-10-20 08:10
3677
Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership
Integrated capabilities, global capacity, and customer-centric innovation
strengthen WuXi AppTec's position in the evolving contract research,
development, and manufacturing (CRDMO) landscape.
SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Frost & Sullivan
2026-10-20 08:00
2388
Can we produce low-cost omega-3s without relying on fish?
GOLD COAST, Australia, Oct. 20, 2026 /PRNewswire/ -- Southern Cross University researchers are aiming to halve the cost of producing omega-3 supplements to make these essential nutrients more accessible to pregnant women and infants in low-income countries, backed by the University's first-ever g...
2026-10-20 06:00
1992
CHANDO Group Showcases Chinese Beauty Science at COSMETIC 360, Debuts Fatigue-Aging Research on Global Stage
PARIS, Oct. 19, 2026 /PRNewswire/ -- CHANDO Group featured its five brands and latest advances in cosmetic ingredient research at the 12th edition of COSMETIC 360, organized by Cosmetic Valley and held at the Louvre in Paris on October 14–15. As a representative of China's beauty industry, the Gr...
2026-10-19 22:28
4313
OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors
— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the United States and in China ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage biopharmaceutical co...
2026-10-19 19:16
2029
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
* Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT). * Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including ...
2026-10-19 13:30
2380
HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the precl...
2026-10-19 11:00
3829
Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies
ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has concluded its inaugural health and life sciences mission to China, advancing priority areas of collaboration designed to accelerate the translation ...
2026-10-18 01:54
6049
The World Egg and Sperm Bank (TWESB) Joins IVI Institute to Expand Access to Reproductive Solutions
SCOTTSDALE, Ariz., Oct. 15, 2026 /PRNewswire/ -- IVI Institute, the global leader in fertility care, today announced that The World Egg and Sperm Bank (TWESB), a trusted provider of donor egg and donor sperm services, has joined its global group. This acquisition expands access to high quality re...
2026-10-15 19:51
1821
Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform
Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines Initial focus on prevalent metabolic dysfunctions where complex disease biology and overlapping comorbidities will benefit from coordinated modulation of multiple therapeutic ta...
2026-10-15 19:30
1981
CCTV+: Workshop on Green Control Technology for Corn Pests and Diseases in the Lancang-Mekong River Basin Successfully Held in Hanoi, Vietnam
BEIJING, Oct. 15, 2026 /PRNewswire/ -- From September 21 to 24, a workshop on Green Control Technology for Corn Pests and Diseases in the Lancang–Mekong River Basin was successfully held in Hanoi, Vietnam. The event was organized by the Institute of Plant Protection (IPP), Chinese Academy of Agri...
2026-10-15 16:04
6587
Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention
Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 study BRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ -- Continuity ...
2026-10-14 20:00
1962
NueCell Bio Joins CIRM's Industry Resource Partner Program to Support California's Stem Cell and Gene Therapy Innovators
SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced today it has joined the Industry Resource Partnership (IRP) Program of the California Institute for Regenerative Medici...
2026-10-14 15:00
2141
Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in ...
2026-10-14 13:00
2937
Likang Life Sciences to Showcase Advances in Personalized Cancer Immunotherapy at Abu Dhabi Future Health Summit 2026
BEIJING, Oct. 14, 2026 /PRNewswire/ -- Likang Life Sciences will serve as a sponsor and exhibitor at the Abu Dhabi Future Health Summit 2026, to be held October 20–22 at the ADNEC Centre in Abu Dhabi, the United Arab Emirates. Shannon Cheung, Co-Founder and Vice Chairman of Likang, will join a pa...
2026-10-14 10:25
2456
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)
SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All Epidermolysis Bullosa (EB) Subtypes This second consecutive nomination places our company and focus on Epidermolysis Bullosa among a select group of visionaries shaping th...
2026-10-14 04:20
2764
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 309 media titles]
2026-10-27 13:40
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 276 media titles]
2026-10-28 09:00
Most Read
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
41103
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
40932
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
40019
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
32251